Research from Switzerland and the Netherlands has discovered that a brain scanning technique measuring delivery of blood to the brain may help to identify people who are at risk of developing memory problems later on.
Author Archives: Laura Phipps
Cardiorespiratory fitness linked to better cognition in mid-life
A new study has shown young adults who take part in cardiorespiratory exercise, such as running, may be more likely to have better thinking and memory skills in middle age.
Growing evidence that infections may drive Alzheimer’s
Researchers at the University of Southampton will present research today suggesting that inflammation in the brain caused by systemic infections could drive the development of Alzheimer’s disease
High-fat diet in pregnancy linked to Alzheimer’s brain changes in offspring
A new study from scientists in Southampton has suggested that diet during pregnancy may affect an offspring’s risk of brain changes linked to Alzheimer’s disease.
Changes in blood may detect Alzheimer’s early
Researchers in the US have discovered changes in people’s blood that may be able to detect Alzheimer’s disease in its earliest stages.
Alzheimer’s disease may be under-reported as cause of death in US
A new study has suggested that the number of deaths caused by Alzheimer’s disease in the US may be nearly six times higher than official figures show.
World Dementia Envoy appointed to speed up treatment development
A new World Dementia Envoy has been appointed to help speed up research into the condition.
Diet linked to build-up of Alzheimer’s protein and cognitive decline
A US study has suggested that diets high in certain compounds may be linked to Alzheimer’s disease, the most common cause of dementia.
Cardiff researchers lead global hunt for early-onset Alzheimer’s risk genes
Welsh researchers taking on an ambitious new research project to uncover risk factors for Alzheimer’s disease are to benefit from £388,920 from Alzheimer’s Research UK, the UK’s leading dementia research charity, thanks to a generous donation from Iceland Foods Charitable Foundation.
Antidepressant may reduce agitation but worsen cognition in Alzheimer’s
A trial of the antidepressant citalopram has found that in people with Alzheimer’s, the drug may reduce agitation but may also carry risks of worsening cognition and heart problems.